HEADLINES: • Bank Pekao: strong 4Q25 delivery bodes well for 2026E outlook POSITIVE • Orlen: 4Q25 results – strong underlying EBITDA POSITIVE • Kruk: buys material portfolio in Italy – very strong start to 2026E in terms of investments scale POSITIVE • Orange Polska: key takeaways from the 4Q25 earnings call NEUTRAL • Mo-BRUK: signs PLN 7.5m contract NEUTRAL • CD Projekt: 4Q25E preview – EBITDA to decline by 48% qoq (due on 19 March) • GEK Terna: EUR 1.1bn planned Vrochonera HPS project secures ...
A director at Coca-Cola Hellenic Bottling Company AG sold 197,435 shares at 4,738p and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
HEADLINES: • AmRest/Sphera Group: no beauty and no beast (AmRest stays BUY, Sphera downgraded to HOLD) • InPost: EUR 15.6 offer from FedEx, Advent, A&R and PPF consortium POSITIVE • Bank Millennium: solid 4Q25 delivery, beat due to tax differences NEUTRAL • PGE: URE initiates proceedings over FWRC settlements NEUTRAL • Auto Partner: January sales growth drops to 3.4% yoy NEGATIVE • Develia: 4Q25E preview – 30% EBITDA drop, following margin normalisation (due on 3 April) • 4iG: 4Q25E preview – 4%...
Over the past year, Sphera’s share price has weathered the macro storm in Romania well, supported by its unique position of being the only consumer name listed locally. At the same time, AmRest has extended its downward move that started in 2024, as investors have kept on questioning the company’s weak earnings momentum and lack of triggers. At its current level of 8x 2026E EBITDA, on our estimates, we see Sphera as fully valued, and we downgrade the name to HOLD (from Buy), with a new price tar...
Key message: Raiffeisen beat market consensus on ex-Russia profit, delivering EUR 416m versus EUR 325m consensus, driven mainly by lower operating costs, lower Polish FX-related expenses, and lower loan-loss impairments, partly offset by significantly weaker other operating income. The lower cost base and reduced impairments point to efficiency improvements and a healthier-than-expected credit environment, reflected in low default levels. Raiffeisen proposed a EUR 1.60 dividend, slightly a...
EME Equity Market – January 2026 All regions in the green in January, with the Turkish ISE the best performer. The MSCI EM Europe Index added 11.1% mom in EUR terms and 13.2% mom in USD terms in January. The Turkish ISE was the top performer (+20.8% mom), followed by the Hungarian BUX (+17.5% mom); the Romanian BET (+11.1% mom); the Greek ASE (+9.2% mom); the Polish WIG 20 (+5.9% mom); and the Czech PX (+2.4% mom; all in EUR terms).
HEADLINES: • Raiffeisen Bank International: preliminary 2025 results, and initial 2026E guidance • Budimex: consortium wins PLN 4bn PKP PLK Rail Baltica tender POSITIVE • Huuuge Games: 3Q25E preview – adjusted EBITDA up 15% qoq (due on 20 March) • OMV: 4Q25E results preview (due on 4 February) NEUTRAL • Krka: preliminary 4Q25 revenues in line, but operating earnings miss NEGATIVE • Short News (HTO, ASELS)
A director at Med Life SA sold 700,000 shares at 11.500RON and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.